LET SCIENCE DO THE TALKING
We are a small molecule drug discovery biotech that uses a target-centric approach and classical medicinal chemistry to identify new medicines
Metastatic melanoma cells
Photo by National Cancer Institute
We are a small molecule drug discovery biotech with an exciting portfolio of research programs that have yielded patent protected drug candidates. Founded in 2010, Curadev has created a premier translational research organization known for prescient target selection and high quality, data-driven program execution. Our programs seek to ameliorate disease by translating cutting edge discoveries into new medicines. We have swiftly established our credentials by successfully creating and out-licensing our small molecule patents to major pharmaceutical companies.
Intuition is the product of persistent practice